Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -320.77% is 351% below its 5-year average of -71.05%, near the low end of its 5-year range (-320.77%–-19.49%).
As of the fiscal period ended Tuesday, June 30, 2026. 94.52% below its 12-month average of -164.90%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -320.77%.
RETURN ON EQUITY (ROE)
-320.77%
RETURN ON EQUITY (ROE) AVG TTM
-164.90%
RETURN ON EQUITY (ROE) AVG 3Y
-94.29%
RETURN ON EQUITY (ROE) AVG 5Y
-71.05%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-94.52%
CURRENT VS 3Y AVG
-240.19%
CURRENT VS 5Y AVG
-351.48%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.89%
median of 684 covered companies
CURRENT VS SECTOR MEDIAN
-684.47%
vs the sector median at left
ClearPoint Neuro, Inc.
Market Cap
$322.84M
Return on Equity (ROE)
-320.77%
TTM Avg
-164.90%
3Y Avg
-94.29%
5Y Avg
-71.05%
Market Cap
$321.93M
Return on Equity (ROE)
N/A
TTM Avg
-541.42%
3Y Avg
-296.61%
5Y Avg
-205.57%
Market Cap
$321.61M
Return on Equity (ROE)
-403.03%
TTM Avg
-329.00%
3Y Avg
-171.64%
5Y Avg
-130.54%
Market Cap
$323.66M
Return on Equity (ROE)
-86.10%
TTM Avg
-112.93%
3Y Avg
-76.30%
5Y Avg
-62.48%
Market Cap
$324.08M
Return on Equity (ROE)
-226.56%
TTM Avg
-87.78%
3Y Avg
-55.09%
5Y Avg
-55.09%
Market Cap
$328.98M
Return on Equity (ROE)
N/A
TTM Avg
34.79%
3Y Avg
145.50%
5Y Avg
100.23%
Market Cap
$315.67M
Return on Equity (ROE)
-41.02%
TTM Avg
-44.84%
3Y Avg
-46.96%
5Y Avg
-38.83%
Market Cap
$304.43M
Return on Equity (ROE)
N/A
TTM Avg
30.84%
3Y Avg
30.84%
5Y Avg
30.84%
Market Cap
$301.12M
Return on Equity (ROE)
-25.73%
TTM Avg
-32.35%
3Y Avg
-2448.72%
5Y Avg
-1749.34%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ClearPoint Neuro, Inc. (CLPT) | $322.84M | -320.77% | -164.90% | -94.29% | -71.05% |
| Avita Medical Inc. (RCEL)vs › | $321.93M | N/A | -541.42% | -296.61% | -205.57% |
| Sanara MedTech Inc. (SMTI)vs › | $321.61M | -403.03% | -329.00% | -171.64% | -130.54% |
| Cabaletta Bio, Inc. (CABA)vs › | $323.66M | -86.10% | -112.93% | -76.30% | -62.48% |
| CapsoVision, Inc. (CV)vs › | $324.08M | -226.56% | -87.78% | -55.09% | -55.09% |
| Agenus Inc. (AGEN)vs › | $328.98M | N/A | 34.79% | 145.50% | 100.23% |
| C4 Therapeutics, Inc. (CCCC)vs › | $315.67M | -41.02% | -44.84% | -46.96% | -38.83% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $304.43M | N/A | 30.84% | 30.84% | 30.84% |
| Benitec Biopharma Inc. (BNTC)vs › | $301.12M | -25.73% | -32.35% | -2448.72% | -1749.34% |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $349.70M | -200.64% | -134.16% | -101.12% | -54.69% |
ROE
-320.8%
ROA
-39.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -320.77% |
| 2026-03-31 | -154.27% |
| 2025-12-31 | -91.15% |
| 2025-09-30 | -145.77% |
| 2025-06-30 | -112.56% |
| 2025-03-31 | -104.04% |
| 2024-12-31 | -74.50% |
| 2024-09-30 | -62.57% |
| 2024-06-30 | -55.96% |
| 2024-03-31 | -59.64% |
| 2023-12-31 | -104.33% |
| 2023-09-30 | -90.71% |
| 2023-06-30 | -76.01% |
| 2023-03-31 | -55.51% |
| 2022-12-31 | -44.55% |
| 2022-09-30 | -40.62% |
| 2022-06-30 | -38.28% |
| 2022-03-31 | -34.62% |
| 2021-12-31 | -29.54% |
| 2021-09-30 | -26.84% |
| 2021-06-30 | -19.49% |
| 2021-03-31 | -16.52% |
| 2020-12-31 | -285.31% |
| 2020-06-30 | -483.99% |
| 2020-03-31 | -230.96% |
| 2019-12-31 | -120.80% |
| 2019-09-30 | -85.09% |
| 2019-06-30 | -78.43% |
| 2018-12-31 | -407.91% |
| 2018-09-30 | -281.92% |
| 2018-06-30 | -197.36% |
| 2018-03-31 | -150.60% |
| 2017-12-31 | -122.97% |
| 2017-09-30 | -92.94% |
| 2017-06-30 | -92.69% |
